Javascript must be enabled to continue!
PLASMA ALDOSTERONE DETERMINATION WITH 35S-p-TOLUENE-SULPHONIC ANHYDRIDE
View through CrossRef
ABSTRACT
The double isotope derivative method for plasma aldosterone, (Bojesen & Thuneberg 1967), has been applied to human peripheral plasma. 35S-p-toluene-sulphonic anhydride was used as the labelled reagent (100–150 mCi/mEq.) and 3H-aldosterone (30 Ci/mm; 0.05 ng added to each sample) as indicator. The initial derivative (aldosterone-21-35S-tosylester) was transformed to its 11,18-γ-lactone and finally to its 3-dinitrophenylhydrazone. Purification was achieved by 1 paper chromatography and 4 thin-layer chromatographies. The overall-recovery was 10 ± 2.7 (sd)%, n = 134. The non-specific blank was 0.053 ± 0.044 (sd), when determined on water samples, and 0.068 ± 0.034 (sd) ng/5 ml, when determined on adrenalectomised human plasmas (non-specific water blank of the same series: 0.064±0.037 (sd) ng). The addition of a known amount of aldosterone to a plasma resulted in a linear relationship over the range examined: y = (0.947 ± 0.013) × + 0.696, P = 0.000, and aldosterone from 1.0 to 5.0 ng was measured with an accuracy of 95%. Replicate measurements of different volumes of the same plasma from 1.0 to 7.5 ml showed a calculated regression line of y = (0.148 ± 0.005) × −0.01, P = 0.002. Replicate measurements of the same plasma (n = 8) gave a mean value of 0.14±0.01 (sd) ng, a range between 0.13 and 0.15 ng and a coefficient of variation of 7%. Thus, it was possible to determine a peripheral plasma level of 7 ng/100 ml in 2 ml plasma and a level of 3.5 ng/100 ml in 4 ml plasma.
Title: PLASMA ALDOSTERONE DETERMINATION WITH 35S-p-TOLUENE-SULPHONIC ANHYDRIDE
Description:
ABSTRACT
The double isotope derivative method for plasma aldosterone, (Bojesen & Thuneberg 1967), has been applied to human peripheral plasma.
35S-p-toluene-sulphonic anhydride was used as the labelled reagent (100–150 mCi/mEq.
) and 3H-aldosterone (30 Ci/mm; 0.
05 ng added to each sample) as indicator.
The initial derivative (aldosterone-21-35S-tosylester) was transformed to its 11,18-γ-lactone and finally to its 3-dinitrophenylhydrazone.
Purification was achieved by 1 paper chromatography and 4 thin-layer chromatographies.
The overall-recovery was 10 ± 2.
7 (sd)%, n = 134.
The non-specific blank was 0.
053 ± 0.
044 (sd), when determined on water samples, and 0.
068 ± 0.
034 (sd) ng/5 ml, when determined on adrenalectomised human plasmas (non-specific water blank of the same series: 0.
064±0.
037 (sd) ng).
The addition of a known amount of aldosterone to a plasma resulted in a linear relationship over the range examined: y = (0.
947 ± 0.
013) × + 0.
696, P = 0.
000, and aldosterone from 1.
0 to 5.
0 ng was measured with an accuracy of 95%.
Replicate measurements of different volumes of the same plasma from 1.
0 to 7.
5 ml showed a calculated regression line of y = (0.
148 ± 0.
005) × −0.
01, P = 0.
002.
Replicate measurements of the same plasma (n = 8) gave a mean value of 0.
14±0.
01 (sd) ng, a range between 0.
13 and 0.
15 ng and a coefficient of variation of 7%.
Thus, it was possible to determine a peripheral plasma level of 7 ng/100 ml in 2 ml plasma and a level of 3.
5 ng/100 ml in 4 ml plasma.
Related Results
ALDOSTERONE IS A VASCULAR CALCIFICATION PROMOTING FACTOR
ALDOSTERONE IS A VASCULAR CALCIFICATION PROMOTING FACTOR
Objectives
Aim: To observe aortic and cardiac aldosterone expression and its receptor changes in rats with vascular calcification, and exogenous aldosterone effec...
35S-Glycosaminoglycan and 35S-Glycopeptide Metabolism by Diabetic Glomeruli and Aorta
35S-Glycosaminoglycan and 35S-Glycopeptide Metabolism by Diabetic Glomeruli and Aorta
35S-glycosaminoglycan metabolism by glomeruli isolated from streptozotocin-diabetic and control rats was studied in vivo and in vitro. Total 35S-glycosaminoglycan synthesis and ret...
CHANGES IN PLASMA ALDOSTERONE FOLLOWING THE ADMINISTRATION OF VARIOUS COMBINATIONS OF STIMULI
CHANGES IN PLASMA ALDOSTERONE FOLLOWING THE ADMINISTRATION OF VARIOUS COMBINATIONS OF STIMULI
ABSTRACT
The effects on plasma aldosterone levels of combinations of the main factors involved in aldosterone regulation have been studied in normal young male subjects. Th...
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
(English) Spacecraft entering planetary atmospheres are enveloped by a plasma layer with high levels of ionization, caused by the extreme temperatures in the shock layer. The charg...
Effects of potassium supplementation on plasma aldosterone: a systematic review and meta-analysis in humans
Effects of potassium supplementation on plasma aldosterone: a systematic review and meta-analysis in humans
Objectives:
Effects of potassium supplementation on blood pressure (BP) may be offset by an increase in plasma aldosterone. The magnitude of potassium-dependent regulat...
Aldosterone and its Regulation during Diuresis in Patients with Gross Congestive Heart Failure
Aldosterone and its Regulation during Diuresis in Patients with Gross Congestive Heart Failure
1. Plasma aldosterone concentration and urine aldosterone excretion were studied before and during sustained diuresis in six patients with gross congestive heart failure, under con...
Renin and Aldosterone Release during Sympathetic Stimulation in Tetraplegia
Renin and Aldosterone Release during Sympathetic Stimulation in Tetraplegia
1. The effect of endogenous sympathetic stimulation (induced by urinary bladder stimulation) and intravenous infusion of noradrenaline and isoprenaline on blood pressure, heart rat...
Aldosterone blunts the baroreflex response in man
Aldosterone blunts the baroreflex response in man
1. Recent animal evidence suggests that aldosterone, like angiotensin II, may possess detrimental autonomic modulating properties. Aldosterone has been shown to impair the barorefl...

